Epinoma was founded by Varun Govil, Zhijian Li in 2020.

Who are Epinoma's investors?

Epinoma's investors include Gaingels, Jude Gomila, Surf Club VC, Y Combinator, Asymmetry Ventures, SeaX Ventures, SeedToB, Sphere 5200 and 1 more.

Where is Epinoma headquartered?

Epinoma is headquartered in San Francisco, US.

Epinoma

YC S21

San Francisco, US · Founded 2020 · 8 employees · Hiring · 9 known investors

Find your way into Epinoma

Paths you didn't know you had: your email and LinkedIn already hold routes to the Epinoma team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Epinoma develops EpiAmp, a methyl-preserving amplification technology to analyze epigenetic changes and methylation patterns for applications in disease detection, drug development, and patient stratification. The company serves research institutions, pharmaceutical companies, and clinical diagnostic organizations in the biotech and healthcare sectors.

AI & Machine Learning Biotech Healthtech Medical Devices Synthetic BiologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S21)

Epinoma was founded in 2020 by Varun Govil and Zhijian Li.

Varun Govil CEO and Co-FounderVarun Govil has a background in translational medicine and prior experience in biotech and medtech development.

Zhijian Li FounderZhijian Li has a background in chemistry and biomedical science with experience developing diagnostic and prognostic methods.

Ishan Goyal

Investors · 9

Gaingelslisted by GaingelsNew York · $200K – $500K

How we know: gaingels.com · Not right? Tell us

Jude Gomilalisted by Jude GomilaLynnwood

How we know: Jude Gomila's portfolio page · Not right? Tell us

Surf Club VClisted by Surf Club VC$100K

How we know: Surf Club VC's portfolio page · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Asymmetry VenturesreportedRichmond · $125K – $500K

How we know: Y Combinator's founder network · Not right? Tell us

SeaX VenturesreportedMillbrae · $100K – $5M

How we know: funding news · Not right? Tell us

SeedToBreportedSuwanee · $500K – $1.5M

How we know: funding news · Not right? Tell us

Sphere 5200reported

How we know: Y Combinator's founder network · Not right? Tell us

Whoa I Lp, By: Whoa Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 7

Ligo BiosciencesLigo develops computational tools for enzyme design by combining large language models with specialized neural networks to enable scientists and AI agents to discover new enzymes and biological functions.

InvertInvert provides infrastructure and intelligence software that connects bioprocess equipment and data sources for pharmaceutical and biologics companies, enabling faster process development and manufacturing through integrated data platforms and digital twin capabilities.

Granza BioGranza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.

Birch BiosciencesBirch Biosciences develops enzyme-based plastic recycling technologies using green chemistry and machine learning to transform plastic waste into reusable material. The company targets the plastic resin market with solutions for industrial and commercial recycling applications.

MolagriMolagri develops biopesticides that target harmful insects through specific molecular mechanisms while protecting beneficial insects and the environment, and incorporates resistance modeling to maintain product efficacy over time.

Epigene LabsEpigene Labs develops AI-powered tools for analyzing genomic data and precision oncology research, serving biopharmaceutical companies and cancer researchers. The company builds software platforms and conducts translational research to support the development of personalized cancer therapies.

Epi BiologicsEpibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.

Companies working in the same space as Epinoma.

Legal entities · 1

corporate structure

Epinoma, Inc.

Frequently asked questions

What does Epinoma do?: Epinoma develops EpiAmp, a methyl-preserving amplification technology to analyze epigenetic changes and methylation patterns for applications in disease detection, drug development, and patient stratification. The company serves research institutions, pharmaceutical companies, and clinical diagnostic organizations in the biotech and healthcare sectors.
Who founded Epinoma?: Epinoma was founded by Varun Govil, Zhijian Li in 2020.
Who are Epinoma's investors?: Epinoma's investors include Gaingels, Jude Gomila, Surf Club VC, Y Combinator, Asymmetry Ventures, SeaX Ventures, SeedToB, Sphere 5200 and 1 more.
Where is Epinoma headquartered?: Epinoma is headquartered in San Francisco, US.